Cargando…
Serum interleukin‐10 as a valuable biomarker for early diagnosis and therapeutic monitoring in intravascular large B‐cell lymphoma
Autores principales: | Zhang, Yan, Wang, Liang, Sun, Jian, Wang, Wei, Wei, Chong, Zhou, Daobin, Zhang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418806/ https://www.ncbi.nlm.nih.gov/pubmed/32634257 http://dx.doi.org/10.1002/ctm2.131 |
Ejemplares similares
-
Cell-Free DNA in Cerebrospinal Fluid Complements the Monitoring Value of Interleukin-10 in Newly Diagnosed Primary Central Nervous System Lymphoma
por: Wang, Wei, et al.
Publicado: (2023) -
Cerebrospinal Fluid IL-10 and IL-10/IL-6 as Accurate Diagnostic Biomarkers for Primary Central Nervous System Large B-cell Lymphoma
por: Song, Yang, et al.
Publicado: (2016) -
Gut Microbiota in Untreated Diffuse Large B Cell Lymphoma Patients
por: Yuan, Li, et al.
Publicado: (2021) -
Changes in cerebrospinal fluid interleukin-10 levels display better performance in predicting disease relapse than conventional magnetic resonance imaging in primary central nervous system lymphoma
por: Zhang, Yan, et al.
Publicado: (2021) -
Post-chemotherapy pneumonia in Chinese patients with diffuse large B-cell lymphoma: Outcomes and predictive model
por: Zhao, Jinrong, et al.
Publicado: (2022)